Advertisement

Picture EBD Group BioPharm America 2019 Boston September 600x60px

News > Ireland

Find below news from the Ireland regions. Listed are news about this region as well as from organisations located there.

Total search results: 248 | Ordered by Date (descending)
1 2 3  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Storm Therapeutics Ltd.. (5/20/19). "Press Release: Storm Therapeutics Extends Series A to GBP 30M (USD 38.43M) with Wew Investor, Seroba Life Sciences". Cambridge. 2019-05-20
ERS Genomics Ltd.. (4/23/19). "Press Release: US Patent Office Grants Charpentier/Doudna Key CRISPR Patent". Dublin. 2019-04-23
ERS Genomics Ltd.. (4/3/19). "Press Release: European Patent Office Grants 3rd Charpentier/Doudna Patent Covering Uses of CRISPR/cas9 in Human and Animal Cells". Dublin. 2019-04-03
Centogene AG. (4/2/19). "Press Release: Centogene Announces the Appointment of Dr. Flemming Ornskov to the Supervisory Board as Non-Executive Chairman". Rostock & Berlin. 2019-04-02
ERS Genomics Ltd.. (3/12/19). "Press Release: ERS Genomics Provides Comment on Issuance of University of California CRISPR/Cas9 Patent including Uses of CRISPR »in a Cell«". Dublin. 2019-03-12
Nabriva Therapeutics plc. (2/19/19). "Press Release: Nabriva Therapeutics Announces Acceptance of New Drug Applications by the FDA for Intravenous and Oral Lefamulin to Treat Community-Acquired Bacterial Pneumonia in Adults". Dublin. 2019-02-19
Nabriva Therapeutics plc. (12/21/18). "Press Release: Nabriva Therapeutics Announces Closing of up to a $75 million Term Loan". Dublin. 2018-12-21
Nabriva Therapeutics plc. (12/20/18). "Press Release: Nabriva Therapeutics Submits New Drug Applications to U.S. Food and Drug Administration for Intravenous and Oral Lefamulin to Treat Community-Acquired Bacterial Pneumonia in Adults". Dublin. 2018-12-20
ERS Genomics Ltd.. (12/13/18). "Press Release: ERS Genomics and Lonza Enter into CRISPR/Cas9 Technology Licensing Deal". Dublin. 2018-12-13
BiomX Ltd.. (12/11/18). "Press Release: BiomX Appoints Sailaja Puttagunta as Chief Medical Officer. BiomX Setting Up Operations to Enter the Clinic in IBD and Additional Indications". Ness Ziona. 2018-12-11
Genomics Medicine Ireland Ltd.. (11/27/18). "Press Release: $400 Million Investment Programme Positions Ireland for Global Leadership in Genomic Research and Advanced Life Sciences". 2018-11-27
Inflazome Ltd.. (11/19/18). "Press Release: Inflazome Completes €40m ($46m) Series B Financing to Develop NLRP3 Inflammasome Inhibitors to Clinical Proof-of-Concept". Dublin & Cambridge. 2018-11-19
Agilent Technologies Inc.. (11/16/18). "Press Release: Agilent Expands Cell Analysis R&D Capabilities in Ireland. New Facility Incorporates Recently Acquired Luxcel Biosciences". Santa Clara, CA. 2018-11-16
Genomics Medicine Ireland Ltd.. (11/7/18). "Press Release: GMI Genomics Centre Awarded CAP-Accreditation". 2018-11-07
Genomics Medicine Ireland Ltd.. (11/6/18). "Press Release: GMI Appoints Dr. Anne Jones as CEO". 2018-11-06
Nabriva Therapeutics plc. (11/6/18). "Press Release: Nabriva Therapeutics Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights". Dublin. 2018-11-06
Nabriva Therapeutics plc. (11/1/18). "Press Release: Nabriva Therapeutics Completes Submission of New Drug Application to U.S. Food and Drug Administration for Intravenous Contepo to Treat Complicated Urinary Tract Infections". Dublin. 2018-11-01
ERS Genomics Ltd.. (11/1/18). "Press Release: ERS Genomics Licenses CRISPR Gene Editing Technology to DefiniGen to Develop Human Cell Models to Support the Preclinical Development of Therapeutics". Dublin & Cambridge. 2018-11-01
ERS Genomics Ltd.. (10/16/18). "Press Release: ERS Genomics and Syngulon Sign License Agreement on CRISPR/Cas9 Genome Editing Patents for Industrial Applications". Dublin & Seraing. 2018-10-16
ERS Genomics Ltd.. (10/4/18). "Press Release: Axcelead Drug Discovery Partners and ERS Genomics Enter into CRISPR/Cas9 License Agreement". Fujisawa & Dublin. 2018-10-04
ERS Genomics Ltd.. (10/4/18). "Press Release: GenAhead Bio and ERS Genomics Enter into CRISPR/Cas9 License Agreement". Fujisawa & Dublin. 2018-10-04
Oxford Genetics Ltd.. (9/20/18). "Press Release: Oxford Genetics Extends Its CRISPR Gene Editing Technology License Agreement from ERS Genomics to Support Its Growth Internationally". Oxford. 2018-09-20
Thermo Fisher Scientific Inc.. (9/18/18). "Press Release: Thermo Fisher Scientific Expands Genome Editing IP Portfolio". Carlsbad, CA. 2018-09-18
BTG plc. (9/7/18). "Press Release: BTG plc Acquires Novate Medical Ltd.". 2018-09-07
Genomics Medicine Ireland Ltd.. (8/30/18). "Press Release: Genomics Medicine Ireland and University of Cambridge Announce Multiple Sclerosis Research Collaboration". Dublin. 2018-08-30
Nabriva Therapeutics plc. (8/9/18). "Press Release: Nabriva Therapeutics Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights". Dublin. 2018-08-09
Nabriva Therapeutics plc. (7/26/18). "Press Release: Nabriva Therapeutics Announces Pricing of Public Offering of Ordinary Shares of Approximately $50 Million". Dublin & King of Prussia, PA. 2018-07-26
Nabriva Therapeutics plc. (7/25/18). "Press Release: Nabriva Therapeutics Announces Proposed Public Offering of Ordinary Shares". Dublin & King of Prussia, PA. 2018-07-25
Nabriva Therapeutics plc. (7/24/18). "Press Release: Nabriva Therapeutics Strengthens Antibiotics Leadership Position with Acquisition of Zavante Therapeutics". Dublin & King of Prussia, PA. 2018-07-24
Argen-X N.V. (Argenx). (7/17/18). "Press Release: Argenx Receives Milestone Payment from Strategic Collaboration with Shire". Breda & Ghent. 2018-07-17
Premier Biosoft International. (7/11/18). "Press Release: Dr. Jonathan Bones Joins Premier Biosoft Scientific Advisory Board to Further the Development of Glycomics Software Solutions for Biopharmaceutical Research and Development". Palo Alto, CA. 2018-07-11
ERS Genomics Ltd.. (5/31/18). "Press Release: ERS Genomics Licenses CRISPR/Cas9 Genome Editing Patents to NMI and NMI TT Pharmaservices". Dublin & Reutlingen. 2018-05-31
Nabriva Therapeutics plc. (5/21/18). "Press Release: Nabriva Therapeutics Announces Positive Topline Results from Pivotal Phase 3 Clinical Trial of Oral Lefamulin for the Treatment of Community-Acquired Bacterial Pneumonia". Dublin & King of Prussia, PA. 2018-05-21
Evotec AG. (5/2/18). "Press Release: Evotec Expands CRISPR-based Technology Offering with Licence from ERS Genomics". Hamburg. 2018-05-02
ERS Genomics Ltd.. (5/2/18). "Press Release: ERS Genomics Licenses CRISPR/Cas9 Genome Editing Patents to Evotec". Dublin. 2018-05-02
Inflection Biosciences Ltd.. (4/16/18). "Press Release: Inflection Biosciences and Trinity College Dublin Announce Immuno-Oncology Research Collaboration". Dublin. 2018-04-16
Servier. (4/16/18). "Press Release: Servier Acquires Shire’s Oncology Business to Gain Direct Commercial Access in the US". Paris. 2018-04-16
ERS Genomics Ltd.. (2/28/18). "Press Release: European Patent Office Grants Second Charpentier/Doudna Patent Covering CRISPR-Cas9 Gene Regulation Applications". Dublin. 2018-02-28
Almac Group Ltd.. (2/28/18). "Press Release: Almac Group Expands with Opening of £20 Million Cold Chain Facility". Craigavon. 2018-02-28
Eurofins Scientific. (2/23/18). "Press Release: Eurofins Becomes the Market Leader in Environment Testing Services in Ireland with the Acquisition of ELS and City Analysts". 2018-02-23
Congenica Ltd.. (2/12/18). "Press Release: Congenica and SFI Research Centre FutureNeuro Unite to Deliver More Accurate Diagnoses for Genetic Epilepsy". Cambridge & Dublin. 2018-02-12
FIRE1 (Foundry Innovation & Research 1, Ltd.). (1/30/18). "Press Release: FIRE1 Raises EUR 40 Million in Series C Financing". Dublin. 2018-01-30
ERS Genomics Ltd.. (1/18/18). "Press Release: ERS Genomics Responds to Revocation of Broad Institute European Patent". Dublin. 2018-01-18
Almac Group Ltd.. (1/18/18). "Press Release: Almac Group Announces Further Expansion at Its European Campus in Dundalk". Craigavon. 2018-01-18
XL-protein GmbH. (1/9/18). "Press Release: Horizon Pharma plc and XL-protein GmbH Have Entered Into a Collaboration Agreement on a Potential Next-Generation Biologic for Uncontrolled Gout Using PASylation® Technology". Freising. 2018-01-09
Agilent Technologies Inc.. (1/9/18). "Press Release: Agilent Expands Cell Analysis Portfolio with Acquisition of Luxcel Biosciences". Santa Clara, CA. 2018-01-09
Mallinckrodt plc. (12/26/17). "Press Release: Mallinckrodt to Acquire Sucampo Pharmaceuticals for approximately $1.2 Billion". Staines-upon-Thames & Rockville, MD. 2017-12-26
Genomics Medicine Ireland Ltd.. (12/11/17). "Press Release: Genomics Medicine Ireland Research Study Aims to Unlock Answers to MS". Cork. 2017-12-11
ERS Genomics Ltd.. (12/6/17). "Press Release: ERS Genomics Licenses CRISPR/Cas9 Genome Editing Patents to Charles River". Dublin. 2017-12-06
ERS Genomics Ltd.. (12/5/17). "Press Release: Horizon Extends Industry-Leading Gene Editing IP Portfolio through Expansion of CRISPR License Rights with ERS Genomics". Dublin & Cambridge. 2017-12-05
Carrick Therapeutics Ltd.. (11/30/17). "Press Release: Carrick Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of iIts Oral CDK7 inhibitor – CT7001". 2017-11-30
Euronext N.V.. (11/29/17). "Press Release: Euronext Expands Its Federal Model with the Acquisition of the Irish Stock Exchange". Amsterdam, et al.. 2017-11-29
ERS Genomics Ltd.. (11/10/17). "Press Release: ERS Genomics and Cellecta, Inc. Sign License Agreement on CRISPR/Cas9 Genome Editing Patents for Tools and Services". Dublin & Mountain View, CA. 2017-11-10
Celgene Corporation. (10/21/17). "Press Release: Celgene Provides Update on GED-0301 (mongersen) Inflammatory Bowel Disease Program". Summit, NJ. 2017-10-21
Nabriva Therapeutics plc. (9/19/17). "Press Release: Nabriva Therapeutics Announces Pricing of Public Offering of Ordinary Shares of Approximately $80 Million". Dublin & King of Prussia, PA. 2017-09-19
Nabriva Therapeutics plc. (9/18/17). "Press Release: Nabriva Therapeutics Announces Positive Topline Results from Global, Phase 3 Clinical Trial Evaluating IV and Oral Lefamulin for the Treatment of Community-Acquired Bacterial Pneumonia". Dublin & King 2017-09-18
Nabriva Therapeutics plc. (9/18/17). "Press Release: Nabriva Therapeutics Announces Proposed Public Offering of Ordinary Shares". Dublin & King of Prussia, PA. 2017-09-18
Bruker Corporation. (9/18/17). "Press Release: Bruker Launches the timsTOF Pro Mass Spectrometer to Enable the Revolutionary PASEF Method for Next-Generation Proteomics". Dublin. 2017-09-18
AB Sciex (d/b/a Sciex). (9/13/17). "Press Release: Meet Sciex and Learn about Industrialized Biomarker Research Using SWATH Acquisition at HUPO 2017". Framingham, MA. 2017-09-13
Carrick Therapeutics Ltd.. (8/30/17). "Press Release: Carrick Therapeutics Appoints Chairman as One of Two New Board Members". Dublin. 2017-08-30
Merck & Co., Inc.. (8/7/17). "Press Release: MSD Animal Health to Purchase Manufacturing Facility in Krems, Austria. European Facility Will Boost Global Vaccine Production Capacity". Madison, NJ. 2017-08-07
Cosmo Pharmaceuticals N.V.. (7/28/17). "Press Release: Cosmo Half-Year Report 2017". Dublin. 2017-07-28
XL-protein GmbH. (7/26/17). "Press Release: Jazz Pharmaceuticals and XL-protein GmbH Enter Into a License Agreement on PASylation Technology to Develop Long-Acting Asparaginase Product Candidates". Freising. 2017-07-26
Cosmo Pharmaceuticals N.V.. (7/26/17). "Press Release: Cosmo Announces European Approval of Qolotag® for Sigmoidoscopies in IBD Patients". Dublin. 2017-07-26
GlaxoSmithKline plc. (7/24/17). "Press Release: Phase II Study Results Showed Comparable Viral Suppression Rates at 96 Weeks for a Two-drug Regimen of Long-acting Cabotegravir and Rilpivirine and a Three-drug Regimen in Patients with HIV". 2017-07-24
Cosmo Pharmaceuticals N.V.. (7/24/17). "Press Release: Cosmo Announces Submission to FDA of New Drug Application for LuMeBlue". Dublin. 2017-07-24
Novimmune S.A.. (7/18/17). "Press Release: Novimmune and Shire Sign License Agreement Deepening Bispecific Antibody Research Collaboration". Geneva. 2017-07-18
ERS Genomics Ltd.. (6/27/17). "Press Release: DuPont Pioneer Secures Exclusive Rights to ERS Genomics’ CRISPR-Cas Patent Portfolio for Agriculture". Johnston, IA & Dublin. 2017-06-27
Waters Corporation. (6/22/17). "Press Release: Waters Corporation Elects Flemming Ornskov to Board of Directors". Milford, MA. 2017-06-22
Thermo Fisher Scientific Inc.. (6/19/17). "Press Release: New Single Quadrupole Mass Spectrometer and Specialized Columns Designed to Deliver Reproducible and Robust Separations, Increase Analytical Accuracy". Prague. 2017-06-19
Cosmo Pharmaceuticals N.V.. (6/1/17). "Press Release: Cosmo Appoints New Head of Investor Relations". Dublin. 2017-06-01
Taconic Biosciences, Inc.. (5/30/17). "Press Release: Taconic Biosciences Secures CRISPR License from ERS Genomics". Hudson, NY. 2017-05-30
Iterum Therapeutics Ltd.. (5/19/17). "Press Release: Iterum Secures $65 Million in Series B Financing. Funding to Support the Phase 3 Clinical Development of Oral Penem Antibiotic". Dublin & Chicago, IL. 2017-05-19
PolyPico Technologies Ltd.. (5/8/17). "Press Release: Precision Gets a Whole New Meaning with the Launch of the PicoPRECISE". Galway. 2017-05-08
Endo International plc. (4/12/17). "Press Release: Endo International plc Announces Pricing of Private Offering of Senior Secured Notes". Dublin. 2017-04-12
HiberGene Diagnostics Ltd.. (4/12/17). "Press Release: HiberGene Closes €6.7m Series B Funding Round". Dublin. 2017-04-12
Endo International plc. (4/10/17). "Press Release: Endo International plc Announces Proposed Private Offering of Senior Secured Notes". Dublin. 2017-04-10
Probiodrug AG. (4/7/17). "Press Release: Last Patient Last Visit (LPLV) Reached in the SAPHIR Study". Halle (Saale). 2017-04-07
Genomics Medicine Ireland Ltd.. (3/30/17). "Press Release: Genomics Medicine Ireland Announces Two Appointments to Its Board. Dr. Kari Stefánsson and Dr. Paul Saunders Appointed to the Board". Dublin. 2017-03-30
Cosmo Pharmaceuticals N.V.. (3/27/17). "Press Release: Cosmo Announces further Expansion of Endoscopy Pipeline with Filing for EU Approval of New Medical Device Qolotag to Enhance Diagnosis in Sigmoidoscopies". Dublin. 2017-03-27
Prothena Corporation plc. (3/3/17). "Press Release: Prothena Announces Pricing of Public Offering of 2,700,000 Ordinary Shares". Dublin. 2017-03-03
Prothena Corporation plc. (3/2/17). "Press Release: Prothena Announces Public Offering of Ordinary Shares". Dublin. 2017-03-02
Luxcel Biosciences Ltd.. (2/15/17). "Press Release: Luxcel Biosciences Ltd, Axiogenesis AG and BMG LABTECH GmbH Secure €2.5m European Investment to Develop and Launch Cell Metabolism Analysis Platform: »MetaCell-TM«". Cork. 2017-02-15
Almac Group Ltd.. (2/14/17). "Press Release: RCSI and Almac Discovery Enter Research Collaboration to Target Therapy-resistant Cancer Tumours". Craigavon. 2017-02-14
Prothena Corporation plc. (2/14/17). "Press Release: Prothena Reports Fourth Quarter and Full Year 2016 Financial Results, and Provides Financial Guidance and R&D Update". Dublin. 2017-02-14
Prothena Corporation plc. (2/8/17). "Press Release: Prothena to Participate in the Leerink Partners 6th Annual Global Healthcare Conference". Dublin. 2017-02-08
Nerre Therapeutics Ltd.. (1/5/17). "Press Release: Nerre Therapeutics Raises £23 Million in Oversubscribed Series B Financing Round". Paris & Boston, MA. 2017-01-05
Iterum Therapeutics Ltd.. (1/5/17). "Press Release: Iterum Announces Sulopenem in Development for Treatment of Gram-Negative, Multi-drug Resistant Infections". Dublin & Chicago, IL. 2017-01-05
Prothena Corporation plc. (1/4/17). "Press Release: Prothena to Participate in the J.P. Morgan Healthcare Conference". Dublin. 2017-01-04
ERS Genomics Ltd.. (12/16/16). "Press Release: CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Announce Global Agreement on the Foundational Intellectual Property for CRISPR/Cas9 Gene Editing Technology". Basel, et al.. 2016-12-16
Inflazome Ltd.. (9/12/16). "Press Release: Inflazome Closes Series A Financing". Dublin. 2016-12-09
Eppendorf AG. (11/3/16). "Press Release: Eppendorf AG Acquires Calibration Technology Ltd". Hamburg. 2016-11-03
Evolva Holding S.A.. (10/27/16). "Press Release: ERS Genomics and Evolva Sign License Agreement on CRISPR-Cas9 Genome Editing Patents for Industrial Applications". Dublin & Reinach. 2016-10-27
Genomics Medicine Ireland Ltd.. (10/26/16). "Press Release: Genomics Medicine Ireland Raises $40 Million in Series A Funding". Dublin. 2016-10-26
Arquer Diagnostics Ltd.. (10/18/16). "Press Release: Arquer Diagnostics Appoints Nadia Whittley as CEO". Sunderland. 2016-10-18
Molecular Partners AG. (10/10/16). "Press Release: Molecular Partners’ Strategic Partner Allergan to Present Abicipar Phase 2 Data of PALM Study in Diabetic Macular Edema (DME) at the 2016 AAO Annual Meeting". Zürich-Schlieren. 2016-10-10
Malin Corporation plc. (10/7/16). "Press Release: Malin Corporation plc Appoints Peter Schwartzman to Senior Management Team". Dublin. 2016-10-07
Evotec AG. (10/4/16). "Press Release: Evotec and Carrick Therapeutics Build Strategic Alliance". Hamburg. 2016-10-04
Carrick Therapeutics Ltd.. (10/3/16). "Press Release: Launch of Carrick Therapeutics Signals New Approach to Cancer Therapies. $95m Initial Funding from Leading Investor Syndicate". Dublin. 2016-10-03
Prothena Corporation plc. (10/3/16). "Press Release: Prothena Announces Appointment of Dr. Gene G. Kinney as President, Chief Executive Officer and Director". Dublin. 2016-10-03
1 2 3  next pagenext page



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture EBD Group BioPharm America 2019 Boston September 600x60px

» top